Related Experiment Video
Updated: Jul 6, 2026
08:44
Dual Test Gas Pulmonary Diffusing Capacity Measurement During Exercise in Humans Using the Single-Breath Method
Published on: February 2, 2024
[Trial end-point in chronic obstructive pulmonary disease (COPD): minimal clinically important difference].
A Gillissen1, R Buhl, P Kardos
1Robert Koch-Klinik, Thoraxzentrum des Klinikums St. Georg Leipzig.
Pneumologie (Stuttgart, Germany)
|March 6, 2008
Summary
The minimal clinically important difference (MCID) helps assess treatment success in COPD patients. However, individual patient perceptions of importance vary, complicating a universal MCID definition.
Area of Science:
- Pulmonary Medicine
- Clinical Trial Design
- Health Outcomes Research
Context:
- The minimal clinically important difference (MCID) is crucial for evaluating treatment efficacy in Chronic Obstructive Pulmonary Disease (COPD).
- Assessing the relevance of statistically significant changes in diagnostic parameters for individual COPD patients is challenging.
- Discrepancies exist between patient and physician perceptions of what constitutes a clinically important difference.
Purpose:
- To provide an update on the concept of minimal important difference for key parameters in COPD treatment.
- To highlight the challenges in defining a universally applicable MCID due to subjective patient perceptions and varying physician interpretations.
- To emphasize the importance of MCID in defining treatment success or failure in clinical trials.
Summary:
- MCID aims to measure the clinical relevance of statistical findings in COPD patients.
- Defining MCID is complex because individual patient priorities differ from generalized measures.
- MCID is essential for determining treatment success and failure in medical research.
Impact:
- This review clarifies the application of MCID in COPD research.
- Understanding MCID variability can lead to more patient-centered treatment evaluations.
- Improved MCID application enhances the interpretation of clinical trial outcomes for COPD interventions.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...